QT Imaging Secures Saudi FDA Clearance for Breast Imaging Tech
Event summary
- QT Imaging's Breast Acoustic CT™ scanner received regulatory clearance from the Saudi Food and Drug Authority (SFDA) on June 3, 2026.
- The clearance allows the company to market, sell, and deploy its technology in Saudi Arabia, a key healthcare market in the Middle East.
- QT Imaging has an exclusive distribution agreement with Gulf Medical Co., a leading healthcare technology provider in Saudi Arabia.
- Saudi Arabia is investing heavily in healthcare modernization and women's health initiatives as part of Vision 2030.
The big picture
QT Imaging's SFDA clearance is a strategic milestone in its international expansion, positioning it to capitalize on Saudi Arabia's Vision 2030 healthcare modernization efforts. The clearance follows a similar approval in the UAE, solidifying the company's presence in the Gulf region's largest healthcare markets. With breast cancer being the most commonly diagnosed cancer among women in Saudi Arabia, the demand for advanced, patient-friendly imaging technologies is growing, creating a significant opportunity for QT Imaging.
What we're watching
- Market Penetration
- How quickly QT Imaging can establish its technology in Saudi Arabia's competitive healthcare market.
- Regulatory Expansion
- Whether the company can secure similar clearances in other Middle Eastern countries.
- Commercial Execution
- The pace at which Gulf Medical Co. can deploy the Breast Acoustic CT™ scanner across healthcare institutions in Saudi Arabia.